このエントリーをはてなブックマークに追加
ID 52317
Sort Key
3
Title Alternative
A preoperative SUVmax greater than the ADCmin of the primary tumour : A predictor of disease recurrence and survival in patients with endometrial cancer
FullText URL
Thumnail 126_11.pdf 631 KB
Author
Haruma, Tomoko
Hayashi, Chiaki
Hongo, Atsushi
Keywords
endometrial cancer
SUVmax
PET/CT
predictor of poor prognosis
Note
平成24年度岡山医学会賞がん研究奨励賞(林原賞・山田賞)受賞論文 (The 2012 Okayama Medical Association Award)
Publication Title
岡山医学会雑誌
Published Date
2014-04-01
Volume
volume126
Issue
issue1
Publisher
岡山医学会
Publisher Alternative
Okayama Medical Association
Start Page
11
End Page
15
ISSN
0030-1558
NCID
AN00032489
Content Type
Journal Article
Related Url
http://www.okayama-u.ac.jp/user/oma/
OAI-PMH Set
岡山大学
language
日本語
Copyright Holders
Copyright (c) 2014 岡山医学会
File Version
publisher
Refereed
True
DOI
Eprints Journal Name
joma
References
1) Annual Report of Oncology Committee of Japan Society of Obstetrics and Gynecology, Tokyo (2011).
2) Inoue T, Yutani K, Taguchi T, Tamaki Y, Shiba E, Noguchi S : Preoperative evaluation of prognosis in breast cancer patients by [(18)F]2-Deoxy-2 -fluoro- D -glucose-positron emission tomography. J Cancer Res Clin Oncol (2004) 130, 273-278.
3) Rajendran JG, Schwartz DL, O'Sullivan J, Peterson LM, Ng P, Scharnhorst J, Grierson JR, Krohn KA : Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer. Clin Cancer Res (2006) 12, 5435-5441.
4) Gambhir SS : Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer (2002) 2, 683-693.
5) Vesselle H, Schmidt RA, Pugsley JM, Li M, Kohlmyer SG, Vallires E, Wood DE : Lung cancer proliferation correlates with [F-18] fluorodeoxyglucose uptake by positron emission tomography. Clin Cancer Res (2000) 6, 3837-3844.
6) Buck A, Schirrmeister H, Kühn T, Shen C, Kalker T, Kotzerke J, Dankerl A, Glatting G, Reske S, Mattfeldt T : FDG uptake in breast cancer : correlation with biological and clinical prognostic parameters. Eur J Nucl Med Mol Imaging (2002) 29, 1317-1323.
7) Kurokawa T, Yoshida Y, Kawahara K, Tsuchida T, Okazawa H, Fujibayashi Y, Yonekura Y, Kotsuji F : Expression of GLUT-1 glucose transfer, cellular proliferation activity and grade of tumor correlate with [F-18]-fluorodeoxyglucose uptake by positron emission tomography in epithelial tumors of the ovary. Int J Cancer (2004) 109, 926-932.
8) Bammer R : Basic principles of diffusion-weighted imaging. Eur J Radiol (2003) 45, 169-184.
9) Zhang J, Tehrani YM, Wang L, Ishill NM, Schwartz LH, Hricak H : Renal masses : characterization with diffusion-weighted MR imaging--a preliminary experience. Radiology (2008) 247, 458-164.
10) Hayashida Y, Hirai T, Morishita S, Kitajima M, Murakami R, Korogi Y, Makino K, Nakamura H, Ikushima I, Yamura M, Kochi M, Kuratsu JI, et al. : Diffusion-weighted imaging of metastatic brain tumors : comparison with histologic type and tumor cellularity. AJNR Am J Neuroradiol (2006) 27, 1419-1425.
11) Kanauchi N, Oizumi H, Honma T, Kato H, Endo M, Suzuki J, Fukaya K, Sadahiro M : Role of diffusion-weighted magnetic resonance imaging for predicting of tumor invasiveness for clinical stage IA non-small cell lung cancer. Eur J Cardiothorac Surg (2009) 35, 706-710.
12) Taouli B, Thakur RK, Mannelli L, Babb JS, Kim S, Hecht EM, Lee VS, Israel GM : Renal lesions : characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging. Radiology (2009) 251, 398-407.
13) Nakamura K, Joja I, Fukushima C, Haruma T, Hayashi C, Kusumoto T, Seki N, Hongo A, Hiramatsu Y : The preoperative SUVmax is superior to ADCmin of the primary tumour as a predictor of disease recurrence and survival in patients with endometrial cancer. Eur J Nucl Med Mol Imaging (2013) 40, 52-60.